Brivudine
Brivudine is a thymidine analogue with antiviral activity, indicated for the early treatment of acute herpes zoster.
Product Specifications
CAS Number
69304-47-8
Product Name Alternative
Bromovinyldeoxyuridine; BVDU
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
CMV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection; Cancer
Assay Protocol
https://www.medchemexpress.com/Brivudine.html
Purity
99.72
Solubility
DMSO : 200 mg/mL (ultrasonic)
Smiles
OC[C@@H]1[C@H](C[C@H](N2C(NC(C(/C=C/Br)=C2)=O)=O)O1)O
Molecular Formula
C11H13BrN2O5
Molecular Weight
333.14
Precautions
H302, H315, H319, H335
References & Citations
[1]Rabasseda X, et al. Brivudine: a herpes virostatic with rapid antiviral activity and once-daily dosing. Drugs Today (Barc) . 2003 May;39 (5) :359-71.|[2]Keam SJ, et al. Brivudin (bromovinyl deoxyuridine) . Drugs. 2004;64 (18) :2091-7; discussion 2098-9.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
AP06349PU-N 100 µg
TGF beta Receptor II (TGFBR2) Rabbit Polyclonal Antibody
Sign In for Pricing
View Details 
